Cerenome, Inc. SEC filings CNSY

Cerenome, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Feb 14, 2011. Its latest annual report, Form ARS, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 2, 2026 (other events). The company's fiscal year ends on December 31.

Cerenome, Inc. SEC filings
Form Description Filed Period
8-K Current report
Other events
Oct 2, 2026 Oct 2, 2026
4 Insider transaction Oct 1, 2026 Oct 1, 2026
4 Insider transaction Oct 1, 2026 Oct 1, 2026
4 Insider transaction Oct 1, 2026 Oct 1, 2026
4 Insider transaction Oct 1, 2026 Oct 1, 2026
4 Insider transaction Oct 1, 2026 Oct 1, 2026
4 Insider transaction Oct 1, 2026 Oct 1, 2026
4 Insider transaction Oct 1, 2026 Oct 1, 2026
D Filing Sep 18, 2026 —
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Sep 10, 2026 Sep 4, 2026
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 14, 2026 Aug 14, 2026
8-K Current report
Bylaw or fiscal year change
Aug 4, 2026 Aug 3, 2026
4 Insider transaction Jul 1, 2026 Jul 1, 2026
4 Insider transaction Jul 1, 2026 Jul 1, 2026
4 Insider transaction Jul 1, 2026 Jul 1, 2026
4 Insider transaction Jul 1, 2026 Jul 1, 2026
4 Insider transaction Jul 1, 2026 Jul 1, 2026
4 Insider transaction Jul 1, 2026 Jul 1, 2026
4 Insider transaction Jul 1, 2026 Jul 1, 2026
S-8 Employee stock plan registration Jun 18, 2026 —
EFFECT Filing Jun 5, 2026 —
8-K Current report
Material agreement
Jun 5, 2026 Jun 1, 2026
CORRESP Letter to the SEC Jun 5, 2026 —
S-3/A Filing Jun 5, 2026 —
UPLOAD Letter from the SEC Jun 4, 2026 —
S-3 Shelf registration Jun 2, 2026 —
4 Insider transaction May 18, 2026 May 14, 2026
4 Insider transaction May 18, 2026 May 14, 2026
4 Insider transaction May 18, 2026 May 14, 2026
4 Insider transaction May 18, 2026 May 14, 2026
4 Insider transaction May 18, 2026 May 14, 2026
4 Insider transaction May 18, 2026 May 14, 2026
4 Insider transaction May 18, 2026 May 14, 2026
8-K Current report
Shareholder vote results
May 15, 2026 May 14, 2026
10-Q Quarterly report May 15, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 15, 2026 May 15, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G Ownership over 5% (passive) May 15, 2026 —
4 Insider transaction Apr 22, 2026 Apr 20, 2026
3 Initial insider ownership Apr 21, 2026 Apr 20, 2026
8-K Current report
Other events
Apr 21, 2026 Apr 20, 2026
8-K Current report
Officer or director change
Apr 9, 2026 Apr 8, 2026
8-K Current report
Other events
Apr 8, 2026 Apr 8, 2026
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
Apr 2, 2026 Apr 1, 2026
4 Insider transaction Apr 1, 2026 Apr 1, 2026
4 Insider transaction Apr 1, 2026 Apr 1, 2026
DEFA14A Additional proxy material Mar 31, 2026 —
ARS Annual report to shareholders Mar 31, 2026 Dec 31, 2025
DEF 14A Proxy statement Mar 31, 2026 May 14, 2026
3 Initial insider ownership Mar 30, 2026 Mar 20, 2026
8-K Current report
Officer or director change
Mar 26, 2026 Mar 20, 2026
8-K Current report
Other events
Mar 12, 2026 Mar 11, 2026
10-K Annual report Mar 12, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 12, 2026 Mar 12, 2026
RW Filing Mar 6, 2026 —
4 Insider transaction Feb 27, 2026 Feb 25, 2026
4 Insider transaction Feb 27, 2026 Feb 25, 2026
8-K Current report
Officer or director change
Feb 13, 2026 Feb 9, 2026
SCHEDULE 13G Ownership over 5% (passive) Jan 22, 2026 —
8-K Current report
Other events
Jan 22, 2026 Jan 22, 2026
8-K Current report
Material agreement, Other events
Jan 16, 2026 Jan 13, 2026
424B4 Prospectus Jan 14, 2026 —
EFFECT Filing Jan 13, 2026 —
S-1MEF Filing Jan 13, 2026 —
CORRESP Letter to the SEC Jan 9, 2026 —
CORRESP Letter to the SEC Jan 9, 2026 —
S-1 Registration statement Jan 9, 2026 —
4 Insider transaction Jan 2, 2026 Jan 1, 2026
4 Insider transaction Jan 2, 2026 Jan 1, 2026
DRS Filing Nov 25, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Nov 17, 2025 Nov 17, 2025
4 Insider transaction Nov 5, 2025 Nov 4, 2025
10-Q Quarterly report Oct 30, 2025 Sep 30, 2025
8-K Current report
Results of operations
Oct 30, 2025 Oct 30, 2025
8-K Current report
Material agreement, New debt
Oct 21, 2025 Oct 16, 2025
4 Insider transaction Oct 3, 2025 Oct 1, 2025
4/A Filing Oct 3, 2025 Aug 13, 2025
4 Insider transaction Oct 3, 2025 Oct 1, 2025
4/A Filing Oct 3, 2025 Aug 13, 2025
8-K Current report
Other events
Aug 26, 2025 Aug 26, 2025
4 Insider transaction Aug 25, 2025 Aug 22, 2025
S-8 Employee stock plan registration Aug 22, 2025 —
4 Insider transaction Aug 15, 2025 Aug 13, 2025
4 Insider transaction Aug 15, 2025 Aug 13, 2025
4 Insider transaction Aug 15, 2025 Aug 13, 2025
4 Insider transaction Aug 15, 2025 Aug 13, 2025
4 Insider transaction Aug 15, 2025 Aug 13, 2025
4 Insider transaction Aug 15, 2025 Aug 13, 2025
4 Insider transaction Aug 15, 2025 Aug 13, 2025
424B3 Prospectus Aug 15, 2025 —
3 Initial insider ownership Aug 15, 2025 Apr 18, 2025
EFFECT Filing Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
8-K Current report
Other events
Aug 14, 2025 Aug 14, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 14, 2025 Aug 14, 2025
8-K Current report
Other events
Aug 13, 2025 Aug 13, 2025
CORRESP Letter to the SEC Aug 12, 2025 —
8-K Current report
Shareholder vote results
Aug 12, 2025 Aug 7, 2025
S-1 Registration statement Aug 12, 2025 —
UPLOAD Letter from the SEC Aug 5, 2025 —
DRS Filing Aug 4, 2025 —
DEFA14A Additional proxy material Aug 1, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 29, 2025 —
RW Filing Jul 25, 2025 —
ARS Annual report to shareholders Jul 21, 2025 Dec 31, 2024
DEF 14A Proxy statement Jul 21, 2025 Aug 7, 2025
8-K Current report
Auditor change
Jul 18, 2025 Jul 16, 2025
PRE 14A Preliminary proxy statement Jul 11, 2025 Aug 7, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jun 25, 2025 —
EFFECT Filing Jun 23, 2025 —
RW Filing Jun 23, 2025 —
424B3 Prospectus Jun 23, 2025 —
8-K Current report
Material agreement, Unregistered share sale
Jun 20, 2025 Jun 17, 2025
S-1/A Amended registration statement Jun 20, 2025 —
S-1 Registration statement Jun 18, 2025 —
CORRESP Letter to the SEC Jun 17, 2025 —
8-K Current report
Material agreement, Change to shareholder rights
Jun 17, 2025 Jun 17, 2025
UPLOAD Letter from the SEC Jun 13, 2025 —
DRS Filing Jun 9, 2025 —
8-K Current report
Listing notice
Jun 6, 2025 Jun 3, 2025
8-K Current report
Results of operations
May 30, 2025 May 30, 2025
10-Q Quarterly report May 30, 2025 Mar 31, 2025
8-K Current report
Listing notice, Regulation FD disclosure
May 23, 2025 May 21, 2025
SCHEDULE 13G Ownership over 5% (passive) May 22, 2025 —
8-K Current report
Listing notice
May 19, 2025 May 16, 2025
NT 10-Q Filing May 15, 2025 Mar 31, 2025
144 Notice of proposed sale May 7, 2025 —
8-K Current report
Bylaw or fiscal year change, Shareholder vote results, Other events
May 2, 2025 May 2, 2025
DEFA14A Additional proxy material May 1, 2025 —
10-K/A Amended annual report Apr 30, 2025 Dec 31, 2024
S-3/A Filing Apr 23, 2025 —
424B3 Prospectus Apr 18, 2025 —
8-K Current report
Officer or director change
Apr 18, 2025 Apr 18, 2025
POS AM Filing Apr 11, 2025 —
UPLOAD Letter from the SEC Apr 11, 2025 —
DEF 14A Proxy statement Apr 10, 2025 May 2, 2025
S-3 Shelf registration Apr 4, 2025 —
CORRESP Letter to the SEC Apr 1, 2025 —
PRER14A Filing Apr 1, 2025 —
10-K Annual report Mar 31, 2025 Dec 31, 2024
RW Filing Mar 31, 2025 —
8-K Current report
Results of operations
Mar 27, 2025 Mar 27, 2025
UPLOAD Letter from the SEC Mar 24, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Mar 18, 2025 —
PRE 14A Preliminary proxy statement Mar 14, 2025 Mar 14, 2025
424B3 Prospectus Mar 10, 2025 —
8-K Current report
Other events
Mar 10, 2025 Mar 7, 2025
424B3 Prospectus Mar 4, 2025 —
8-K Current report
Material agreement, Unregistered share sale
Mar 4, 2025 Mar 4, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
424B3 Prospectus Feb 18, 2025 —
8-K Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
Feb 18, 2025 Feb 13, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 10, 2025 —
8-K Current report
Results of operations
Nov 14, 2024 Nov 14, 2024
424B3 Prospectus Nov 14, 2024 —
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
424B3 Prospectus Nov 1, 2024 —
8-K Current report
Other events
Nov 1, 2024 Oct 30, 2024
S-3 Shelf registration Oct 4, 2024 —
4 Insider transaction Sep 17, 2024 Sep 13, 2024
4 Insider transaction Sep 16, 2024 Sep 12, 2024
4 Insider transaction Sep 13, 2024 Sep 11, 2024
4 Insider transaction Sep 13, 2024 Sep 11, 2024
4 Insider transaction Sep 12, 2024 Sep 11, 2024
4 Insider transaction Sep 12, 2024 Sep 11, 2024
4 Insider transaction Sep 12, 2024 Sep 11, 2024
4 Insider transaction Sep 12, 2024 Sep 11, 2024
4 Insider transaction Sep 12, 2024 Sep 11, 2024
4 Insider transaction Sep 12, 2024 Sep 11, 2024
4 Insider transaction Sep 12, 2024 Sep 11, 2024
4 Insider transaction Sep 11, 2024 Sep 10, 2024
4 Insider transaction Sep 11, 2024 Sep 10, 2024
424B3 Prospectus Sep 6, 2024 —
8-K Current report
Listing notice
Sep 6, 2024 Sep 5, 2024
S-8 Employee stock plan registration Aug 23, 2024 —
424B3 Prospectus Aug 15, 2024 —
8-K Current report
Shareholder vote results
Aug 15, 2024 Aug 15, 2024
424B3 Prospectus Aug 14, 2024 —
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 14, 2024 Aug 14, 2024
DEFA14A Additional proxy material Jul 12, 2024 —
ARS Annual report to shareholders Jul 10, 2024 Dec 31, 2023
DEF 14A Proxy statement Jul 10, 2024 Aug 15, 2024
EFFECT Filing Jun 24, 2024 —
424B3 Prospectus Jun 24, 2024 —
S-1/A Amended registration statement Jun 24, 2024 —
CORRESP Letter to the SEC Jun 20, 2024 —
UPLOAD Letter from the SEC Jun 14, 2024 —
S-1 Registration statement Jun 7, 2024 —
8-K Current report
Officer or director change
Jun 7, 2024 Jun 5, 2024
SC 13G Ownership over 5% (passive) Jun 5, 2024 —
8-K Current report
Material agreement, Agreement ended, New debt
Jun 4, 2024 May 31, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
CNSY (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Houston, TX
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1095981
Former names
PLUS THERAPEUTICS, INC. (until Jul 1, 2026); CYTORI THERAPEUTICS, INC. (until Aug 2, 2019); MACROPORE INC (until Jul 5, 2005)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.